Jeremy G. Chadwick

Insider Reports History

Location
Watertown, MA
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeremy G. Chadwick:

Company Role Class Num Shares Value Price $ Report Date Ownership
Kymera Therapeutics, Inc. Chief Operating Officer Common Stock 73,810 $6,393,769 $86.62 04 Mar 2026 Direct
Kymera Therapeutics, Inc. Chief Operating Officer Stock Option (Right to Buy) 25,150 02 Mar 2026 Direct

Insider Reports Filed by Jeremy G. Chadwick

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KYMR Kymera Therapeutics, Inc. 02 Mar 2026 9 -$515,594 4 Chief Operating Officer 04 Mar 2026, 18:00
KYMR Kymera Therapeutics, Inc. 23 May 2025 1 -$75,436 4 Chief Operating Officer 23 May 2025, 16:30
KYMR Kymera Therapeutics, Inc. 03 Mar 2025 4 -$42,113 4 Chief Operating Officer 03 Mar 2025, 18:30
KYMR Kymera Therapeutics, Inc. 23 May 2024 1 -$90,105 4 Chief Operating Officer 23 May 2024, 16:10
KYMR Kymera Therapeutics, Inc. 01 Mar 2024 2 $0 4 Chief Operating Officer 04 Mar 2024, 18:16
KYMR Kymera Therapeutics, Inc. 22 May 2023 2 $0 4 Chief Operating Officer 22 May 2023, 19:35
KYMR Kymera Therapeutics, Inc. 22 May 2023 0 $0 3 Chief Operating Officer 22 May 2023, 19:28